119 related articles for article (PubMed ID: 21429822)
1. Preconceptional identification of cystic fibrosis carriers in the Sardinian population: A pilot screening program.
Coiana A; Faa' V; Carta D; Puddu R; Cao A; Rosatelli MC
J Cyst Fibros; 2011 May; 10(3):207-11. PubMed ID: 21429822
[TBL] [Abstract][Full Text] [Related]
2. Carrier screening for cystic fibrosis.
Dungan JS
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
[TBL] [Abstract][Full Text] [Related]
3. Screening of CFTR mutations in an isolated population: identification of carriers and patients.
Chiba-Falek O; Nissim-Rafinia M; Argaman Z; Genem A; Moran I; Kerem E; Kerem B
Eur J Hum Genet; 1998; 6(2):181-4. PubMed ID: 9781064
[TBL] [Abstract][Full Text] [Related]
4. A new insertion/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening.
Faà V; Bettoli PP; Demurtas M; Zanda M; Ferri V; Cao A; Rosatelli MC
J Mol Diagn; 2006 Sep; 8(4):499-503. PubMed ID: 16931591
[TBL] [Abstract][Full Text] [Related]
5. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
6. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
[TBL] [Abstract][Full Text] [Related]
7. Geographic distribution of cystic fibrosis transmembrane regulator gene mutations in Saudi Arabia.
Banjar H
East Mediterr Health J; 1999 Nov; 5(6):1230-5. PubMed ID: 11924117
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
[TBL] [Abstract][Full Text] [Related]
9. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
10. Screening for mutations in the cystic fibrosis transmembrane regulator gene in an infertility clinic.
Slostad J; Stein QP; Flanagan JD; Hansen KA
Fertil Steril; 2007 Dec; 88(6):1687-8. PubMed ID: 17482604
[TBL] [Abstract][Full Text] [Related]
11. All azoospermic males should be screened for cystic fibrosis mutations before intracytoplasmic sperm injection.
Mocanu E; Shattock R; Barton D; Rogers M; Conroy R; Sheils O; Collins C; Martin C; Harrison R; O'Leary J
Fertil Steril; 2010 Nov; 94(6):2448-50. PubMed ID: 20381036
[TBL] [Abstract][Full Text] [Related]
12. A 10-year large-scale cystic fibrosis carrier screening in the Italian population.
Picci L; Cameran M; Marangon O; Marzenta D; Ferrari S; Frigo AC; Scarpa M
J Cyst Fibros; 2010 Jan; 9(1):29-35. PubMed ID: 19897426
[TBL] [Abstract][Full Text] [Related]
13. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
[TBL] [Abstract][Full Text] [Related]
15. CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs.
Keyeux G; Rodas C; Bienvenu T; Garavito P; Vidaud D; Sanchez D; Kaplan JC; Aristizábal G
Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938099
[TBL] [Abstract][Full Text] [Related]
16. High incidence of the CFTR mutations 3272-26A-->G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A-->G, E588V, and 1671insTATCA).
Storm K; Moens E; Vits L; De Vlieger H; Delaere G; D'Hollander M; Wuyts W; Biervliet M; Van Schil L; Desager K; Nöthen MM
J Cyst Fibros; 2007 Nov; 6(6):371-5. PubMed ID: 17481968
[TBL] [Abstract][Full Text] [Related]
17. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
[TBL] [Abstract][Full Text] [Related]
18. Distribution of CFTR mutations in Eastern Hungarians: relevance to genetic testing and to the introduction of newborn screening for cystic fibrosis.
Ivady G; Madar L; Nagy B; Gonczi F; Ajzner E; Dzsudzsak E; Dvořáková L; Gombos E; Kappelmayer J; Macek M; Balogh I
J Cyst Fibros; 2011 May; 10(3):217-20. PubMed ID: 21296036
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in idiopathic pancreatitis.
Castellani C; Gomez Lira M; Frulloni L; Delmarco A; Marzari M; Bonizzato A; Cavallini G; Pignatti P; Mastella G
Hum Mutat; 2001 Aug; 18(2):166. PubMed ID: 11462247
[TBL] [Abstract][Full Text] [Related]
20. CFTR H609R mutation in Ecuadorian patients with cystic fibrosis.
Moya-Quiles MR; Glover G; Mondéjar-López P; Pastor-Vivero MD; Fernández-Sánchez A; Sánchez-Solís M
J Cyst Fibros; 2009 Jul; 8(4):280-1. PubMed ID: 19457724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
